This study, published in the Journal of Sleep Research, explores the relationship between sleep duration and serum brain-derived neurotrophic factor (BDNF) levels in adolescents at risk for type 2 diabetes (T2D). Conducted by Dutil et al., the research involved a randomized crossover design with 36 adolescent participants, aged approximately 15 years, who were classified as severely obese.
The participants underwent two sleep manipulation conditions: an increase in sleep duration by 1.5 hours per night and a decrease by the same amount, each lasting one week. A one-week washout period of habitual sleep was included between these conditions. The study aimed to assess how these changes in sleep duration would affect serum BDNF levels, a protein linked to neuroplasticity and metabolic health.
Results indicated that increasing sleep duration led to a significant decrease in serum BDNF levels by approximately 14% compared to both the habitual and decreased sleep conditions. Conversely, no significant differences were noted between the habitual and decreased sleep conditions. This finding suggests that longer sleep duration may influence BDNF levels in a way that is not yet fully understood.
The authors propose that lower BDNF levels following sleep extension, along with improvements in insulin sensitivity observed in previous studies, could indicate reduced physiological stress or a compensatory mechanism in neurotrophic signaling. However, the exact mechanisms behind these changes remain unclear.
Interestingly, higher BDNF levels during habitual and restricted sleep may reflect adaptive responses to insufficient sleep rather than indicating improved metabolic function. This study provides the first experimental evidence linking sleep duration manipulation to changes in serum BDNF levels in this specific population.
What this study does not show
This study does not establish a direct causal relationship between changes in BDNF levels and metabolic outcomes in adolescents at risk for type 2 diabetes.
Evidence scorecard
- Analytic validity: established
- Clinical validity: established
- Clinical utility: partial
The evidence class is human_rct, indicating that the findings are based on a randomized controlled trial involving human participants.